Woodline Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.6M | Buy |
1,425,670
+222,325
| +18% | +$5.39M | 0.18% | 156 |
|
|
2025
Q1 | $30.5M | Sell |
1,203,345
-115,145
| -9% | -$2.92M | 0.2% | 159 |
|
|
2024
Q4 | $35M | Buy |
1,318,490
+191,957
| +17% | +$5.09M | 0.24% | 132 |
|
|
2024
Q3 | $32.6M | Buy |
1,126,533
+55
| +0% | +$1.59K | 0.27% | 117 |
|
|
2024
Q2 | $31.5M | Buy |
1,126,478
+1,757
| +0.2% | +$49.2K | 0.3% | 102 |
|
|
2024
Q1 | $31.2M | Sell |
1,124,721
-366,317
| -25% | -$10.2M | 0.29% | 107 |
|
|
2023
Q4 | $42.9M | Buy |
1,491,038
+1,191,152
| +397% | +$34.3M | 0.47% | 62 |
|
|
2023
Q3 | $9.95M | Buy |
299,886
+24,827
| +9% | +$824K | 0.12% | 225 |
|
|
2023
Q2 | $10.1M | Sell |
275,059
-38,578
| -12% | -$1.42M | 0.12% | 206 |
|
|
2023
Q1 | $12.8M | Buy |
313,637
+158
| +0.1% | +$6.45K | 0.17% | 165 |
|
|
2022
Q4 | $16.1M | Sell |
313,479
-313,374
| -50% | -$16.1M | 0.21% | 136 |
|
|
2022
Q3 | $27.4M | Hold |
626,853
| – | – | 0.38% | 72 |
|
|
2022
Q2 | $32.9M | Hold |
626,853
| – | – | 0.51% | 40 |
|
|
2022
Q1 | $32.5M | Sell |
626,853
-362,770
| -37% | -$18.8M | 0.53% | 49 |
|
|
2021
Q4 | $58.4M | Sell |
989,623
-205,447
| -17% | -$12.1M | 0.84% | 23 |
|
|
2021
Q3 | $51.4M | Buy |
1,195,070
+610,969
| +105% | +$26.3M | 0.84% | 23 |
|
|
2021
Q2 | $22.9M | Buy |
584,101
+27,026
| +5% | +$1.06M | 0.43% | 60 |
|
|
2021
Q1 | $20.2M | Buy |
+557,075
| New | +$20.2M | 0.45% | 69 |
|
|
2020
Q2 | – | Sell |
-2,120,811
| Closed | -$65.7M | – | 178 |
|
|
2020
Q1 | $65.7M | Buy |
+2,120,811
| New | +$65.7M | 4.69% | 1 |
|